Biotechnology Progress

Papers
(The H4-Index of Biotechnology Progress is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Optimized pulse‐feeding fed‐batch fermentation for enhanced lignin to polyhydroxyalkanoate transformation105
Depth filtration for clarification of intensified lentiviral vector suspension cell culture69
Establishment and characterization of lung co‐culture spheroids for paclitaxel loaded Eudragit® RL 100 nanoparticle evaluation66
Retrospective assessment of clonality of a legacy cell line by analytical subcloning of the master cell bank50
Acetate accumulation and regulation by process parameters control in Chinese hamster ovary cell culture41
The effects of the chemical modification on immobilized lipase features are affected by the enzyme crowding in the support39
Proteomics‐based method to comprehensively model the removal of host cell protein impurities32
Issue Information27
From protein structure to an optimized chromatographic capture step using multiscale modeling26
High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditions22
Pre‐folding purification procedures for inclusion body‐derived non‐tagged cationic recombinant proteins with multiple disulfide bonds for efficient refolding22
Dynamic flux balance analysis of 1,3‐propanediol production by clostridium butyricum fermentation21
Genetically engineered neural stem cells (NSCs) therapy for neurological diseases; state‐of‐the‐art20
Online monitored characterization of Phocaeicola vulgatus for organic acid production using anaerobic microtiter plate cultivations20
Current status of platelet manufacturing in 3D or bioreactors19
Removal of chromatin by salt‐tolerant endonucleases for production of recombinant measles virus19
Issue Information18
The production of succinate with more CO2 fixation reactions facilitated by RuBisCO‐based engineered Escherichia coli17
Evaluating multiproduct chromatography Protein A resin reuse for monoclonal antibodies in biopharmaceutical manufacturing17
0.12386918067932